Twin City Private Wealth’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59M Buy
4,402
+41
+0.9% +$14K 1.12% 30
2026
Q1
$1.53M Buy
4,361
+45
+1% +$16K 1.16% 36
2025
Q4
$1.41M Buy
4,316
+33
+0.8% +$10.5K 1.07% 36
2025
Q3
$1.21M Buy
4,283
+95
+2% +$27.6K 0.94% 41
2025
Q2
$1.17M Buy
4,188
+22
+0.5% +$6.23K 0.96% 38
2025
Q1
$1.3M Sell
4,166
-356
-8% -$105K 1.14% 34
2024
Q4
$1.18M Sell
4,522
-234
-5% -$69.4K 1.04% 36
2024
Q3
$1.53M Buy
4,756
+57
+1% +$18.6K 1.33% 34
2024
Q2
$1.47M Sell
4,699
-195
-4% -$57.3K 1.39% 33
2024
Q1
$1.39M Buy
+4,894
New +$1.43M 1.37% 32

Other funds holding AMGN

Twin City Private Wealth's AMGN Position: Q2 2026 in Review

Twin City Private Wealth increased its Amgen (AMGN) stake by 0.94% in Q2 2026, buying an estimated $14K and bringing the position to 4,402 shares worth $1.59M. The position accounts for 1.12% of the portfolio, ranked #30.

Twin City Private Wealth first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Twin City Private Wealth held 4,402 shares of Amgen worth $1.59M as of Q2 2026.
  • Twin City Private Wealth bought 41 Amgen shares in Q2 2026, an estimated $14K.
  • Amgen made up 1.12% of Twin City Private Wealth's portfolio in Q2 2026, its #30 holding.
  • Twin City Private Wealth first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Twin City Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.